欧洲过敏反应治疗市场预测至 2028 年 - 按药物类型（肾上腺素、抗组胺药、类固醇、β 激动剂等）、给药途径（口服、肠胃外等）、过敏类型（食物过敏）划分的 COVID-19 影响和区域分析、药物、昆虫叮咬等）和分销渠道（医院药房、零售等）
No. of Pages: 156 | Report Code: TIPRE00023951 | Category: Life Sciences
No. of Pages: 156 | Report Code: TIPRE00023951 | Category: Life Sciences
过敏反应是一种过敏反应，可进一步导致称为过敏性休克的致命疾病。当患者的身体对异物产生反应并产生大量组胺从而引发炎症反应时，就会发生过敏反应。这是一种严重的、危及生命的过敏反应，其症状包括吞咽和呼吸困难、皮肤瘙痒和血压降低。
因此，过敏反应发生率的上升预计将对过敏反应产生巨大的需求未来几年的治疗，预计这将进一步推动过敏反应治疗市场。
欧洲 COVID-19 病例的快速增长对欧洲经济产生了重大影响。西班牙、意大利、德国、法国和英国是受影响最严重的欧洲国家。它与欧洲过敏和临床免疫学学会 (EAACI) 合作，出版了《过敏及其对哮喘的影响 (ARIA)》。各自领域的专家最近出版了一份纲要，其中回答了 150 个有关 COVID-19 和过敏性疾病的常见问题。此外，读者还可以对这个“生活”提出进一步的问题。概要以电子方式提供给作者，他们的答案将通过期刊网页上的新类别提供。此外，EAACI 与 ARIA 合作，提供了操作计划和实际程序的建议，以确保过敏性疾病患者日常临床护理的最佳标准，同时确保患者和医护人员的安全。因此，在欧洲，人们对 COVID-19 相关过敏的认识不断提高，可能会增加对 COVID 大流行期间过敏反应治疗和供应的需求，从而促进过敏反应治疗市场的增长。
欧洲过敏反应治疗市场预计将从 2021 年的 5.34 亿美元增长到 2028 年的 9.872 亿美元；预计 2021 年至 2028 年复合年增长率为 9.2%。接种 COVID-19 疫苗后已观察到过敏病例。除此之外，有过敏反应史的患者应携带肾上腺素自动注射器，以便在预约疫苗接种时携带。除了这一举措之外，COVID-19 疫苗接种场所还应随时准备好至少三剂肾上腺素，并且能够在给患者注射肾上腺素后更换用品。然而，作为 AEFI 的过敏反应并不常见，大多数疫苗的发生率不到百万分之一。这些因素为当前 COVID-19 情况下过敏反应治疗市场的增长提供了机会。
从药物类型来看，2020年欧洲过敏反应治疗市场中，肾上腺素细分市场占据最大份额。从给药途径来看，注射给药细分市场占据最大份额。 2020年欧洲过敏反应治疗市场。就过敏类型而言，食物过敏细分市场占2020年欧洲过敏反应治疗市场的最大份额。就分销渠道而言，零售药房细分市场占有较大的过敏反应市场份额2020年治疗市场。
准备本欧洲过敏反应治疗市场报告时提到的一些主要一手和二手来源包括公司网站、年度报告、财务报告、国家政府文件和统计数据库，其中其他的。报告中列出的主要公司包括 Amneal Pharmaceuticals Inc.、Mylan NV、BIOPROJET、Abbott、Pfizer Inc.、Glaxosmithkline Plc.、Merck and Co., Inc.、Teva Pharmaceutical Industries Ltd. 和 ALK-ABELLó。
按药物类型
作者给药途径
按过敏类型
按分销渠道
按国家/地区
Strategic insights for Europe Anaphylaxis Treatment involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 534.0 Million |
| Market Size by 2028 | US$ 987.2 Million |
| Global CAGR (2021 - 2028) | 9.2% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 药物类型
|
| Regions and Countries Covered | 欧洲
|
| Market leaders and key company profiles |
The regional scope of Europe Anaphylaxis Treatment refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Anaphylaxis Treatment Market is valued at US$ 534.0 Million in 2021, it is projected to reach US$ 987.2 Million by 2028.
As per our report Europe Anaphylaxis Treatment Market, the market size is valued at US$ 534.0 Million in 2021, projecting it to reach US$ 987.2 Million by 2028. This translates to a CAGR of approximately 9.2% during the forecast period.
The Europe Anaphylaxis Treatment Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Anaphylaxis Treatment Market report:
The Europe Anaphylaxis Treatment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Anaphylaxis Treatment Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Anaphylaxis Treatment Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Anaphylaxis Treatment Market
